ENSRF yields 2000000.00% · PFE yields 6.13%● Live data
📍 ENSRF pulled ahead of the other in Year 1
Combined, ENSRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENSRF + PFE for your $10,000?
Enseco Energy Services Corp., together with its subsidiaries, provides energy related services and rentals to the upstream oil and gas industry in Canada and the United States. The company offers directional and horizontal drilling services; production testing; and frac flowback services. It provides drilling tools and services, such as performance drilling motors; electromagnetic, negative pulse, enseco edge positive pulse, Gamma-Ray LWD, and resistivity measurement tools; drilling motor facilities; and well planning and directional modeling torques and drags, as well as BHA design, anti-collision analysis, and repair and manufacturing services. The company's production services product line includes p-tanks, frac flowback, in-line testing, bleed offs, stimulation recovery, sour service capability, portable and skid mounted configurations, zero ground disturbance flare stacks and office trailers, flow lines rated to 10,000 psi, and vessels rated from 200 to 1,440 psi. In addition, it offers well stimulation frac flowback services; and oil and gas production testing. Enseco Energy Services Corp. was incorporated in 2006 and is based in Calgary, Canada.
Full ENSRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.